Effects of CCR5 genetic polymorphism and HIV-1 subtype in antiretroviral response in Brazilian HIV-1-infected patients

J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):399-400. doi: 10.1097/00126334-200008010-00016.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Brazil
  • CD4 Lymphocyte Count
  • Double-Blind Method
  • HIV Infections / drug therapy
  • HIV Infections / genetics*
  • HIV Infections / virology*
  • HIV-1 / classification*
  • Heterozygote
  • Humans
  • Polymorphism, Genetic*
  • Receptors, CCR5 / genetics*

Substances

  • Anti-HIV Agents
  • Receptors, CCR5